TITLE

INVEST NEW JERSEY

AUTHOR(S)
Ruth, Joao-Pierre S.
PUB. DATE
August 2000
SOURCE
Business News New Jersey;08/22/2000, Vol. 13 Issue 34, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on financial information about a pharmaceutical company called Alpharma in Fort Lee, New Jersey. Decline in share prices in August 2000; Favorable financial report for the second quarter of 2000; Acquisition of Roche's medicated animal feed additive business; Sale of shares of Class A common stock to Donaldson Lufkin and Jenrette Securities and Banc of America Securities.
ACCESSION #
3511946

 

Related Articles

  • On Track on the March.  // njbiz;11/13/2006, Vol. 19 Issue 46, p39 

    The article features On Track Innovations in Fort Lee, New Jersey, which bought the main assets of SuperCom of Qadima, Israel in exchange for two million-worth of On Track shares. The deal includes the acquisition of Supercom's International Project Solution that generates around 95 percent of...

  • Courtisan reorganizes sales markets.  // Home Textiles Today;12/2/2002, Vol. 24 Issue 13, p16 

    Reports on the reorganization of the sales executives for the Couristan Inc. in Fort Lee, New Jersey. Designation of George Marinovich to manage accounts; Promotion of Tom McKay; Statement of Larry Mahurter, director of advertising and sales on reorganization.

  • Delightfully Deluxe. Giardina, Carolyn // Hollywood Reporter Weekend Edition;7/17/2009, Vol. 410 Issue 34, p18 

    The article focuses on developments related to Twentieth Century Fox Films Corp. in Fort Lee, New Jersey during 1915-2006. It was founded by William G. Fox in 1915. A patent for the sound-on-film process was acquired by Deluxe, a film and camera department of Fox in 1927. In 1935, 20th Century...

  • New model for Alpharma.  // Life Science Today;Apr2001, Vol. 2 Issue 2, p4 

    Reports on the installation of the first Zanchetta MS2000 powder and granule blender in Great Britain at the site of Alpharma Inc. Number of tablets in the therapeutic area supplied by the generics company.

  • Acquisition, higher sales bring revenue increase for Alpharma.  // Drug Store News;12/14/98, Vol. 20 Issue 20, pCP14 

    Cites the financial performance of Alpharma Inc. for the third quarter of 1998. Rise in the company's revenue and operating income.

  • Apothecary Loves Company.  // njbiz;4/9/2007, Vol. 20 Issue 15, p2 

    The article reports on the decision of the growing specialty pharmaceutical company Alpharma Inc. to move its headquarters from Fort Lee to Bridgewater, New Jersey. According to vice president of investor services Kathleen Makrakis, the decision has something to do with the need for the company...

  • A Disappointing Forecast. Nelson, Jennifer // njbiz;9/15/2003, Vol. 16 Issue 37, p25 

    Analyzes the performance of the stocks of Alpharma in the stock market as of September 15, 2003. Decline in the stocks of the pharmaceutical company; Decision of lower the financial forecast of the company; Forecast on the profit of the company.

  • Leaving Norway.  // njbiz;2/11/2008, Vol. 21 Issue 7, p31 

    The article reports that Bridgewater, New Jersey-based Alpharma Inc. sold its pharmaceutical ingredients to London, England-based, private equity firm 3i. After taxes and fees are applied, Alpharma expects to generate $365 million from the $395 million deal in net proceeds. Its division in Oslo,...

  • A Painkiller Binds Twin Pharma Deals. P., Shankar // njbiz;1/5/2009, Vol. 22 Issue 1, p2 

    The article reports on the completion of two major pharmaceutical acquisitions that center on the pain drug Kadian from Alpharma in the U.S. in December 2008. Alpharma Inc. was acquired by Bristol, Tennessee-based King Pharmaceuticals Inc. for $1.6 billion. Kadian was sold to Iceland-based...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics